FGF23 and chronic kidney disease: Since then, a large number of clinical studies have shown that high plasma concentrations of FGF23 are associated with left ventricular hypertrophy (LVH), heart failure, and mortality in the general population, and especially in patients with chronic kidney disease (CKD).